Newer Biological Agents in the Treatment of Severe Asthma: Real-World Results from a Tertiary Referral Center

ConclusionsIL-5 inhibitory therapy is associated with significant and long-term sustained reductions in asthma exacerbation frequency, ER visits, hospitalizations, as well as oral steroid usage in a patient population with refractory steroid-dependent asthma referred to a tertiary referral center.
Source: Lung - Category: Respiratory Medicine Source Type: research